Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...

Many Mounjaro users have considered making the swap after Eli Lilly announced prices would be increasing in the UK by 170 ...

Erin* has been using weight loss jabs for over six months. Desperate to lose 20kg, the 33-year-old first turned to Mounjaro at the end of last year. However, although it helped her shed the pounds, it ...

Taking meds to lose weight has been surging among Americans. While these drugs are safe, they have one drawback, they can also cause muscle mass loss.

Mounjaro (tirzepatide) : Lilly's dual GIP/GLP-1 agonist has delivered best-in-class weight loss and glycemic control in T2D and, under its obesity brand Zepbound , has outperformed semaglutide in head ...

Biotech firm Vivani Medical has joined hands with Okava to work on a canine-friendly version of weight loss medications ...

Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some ...

Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to ...

Its amazing results have been hailed by Jeremy Clarkson, Whoopi Goldberg and The Telegraph’s own Allison Pearson, but from next month, the popular weight-loss drug Mounjaro could become inaccessible ...

Influencer Tana Mongeau questioned if she had Ozempic vulva on TikTok, after reported side effect goes viral online.

At six months, people taking Mounjaro shed 10.1% of their weight, while patients on Ozempic lost 5.9% Eli Lilly’s Mounjaro patients “were significantly more likely to achieve 5%, 10% and 15% ...

"This retrospective cohort study found that taking GLP-1RAs was associated with a reduced overall risk of cancer, including lower risks of endometrial, ovarian, and meningioma cancers, among patients ...